In January 2004, the first product in Respimat® SMI, Berodual® Respimat®, was launched in Germany. Berodual® is a combination product of 20 microgram ipratropium bromide and 50 microgram fenoterol hydrobromide. Berodual® has been available in countries all over the world for many years and is provided through an MDI. Since January 2004 Berodual® has, for the first time, also been available through the new generation inhaler Respimat® SMI that provides several advantages for patients compared to the MDI.
Here you will find the summary of product characteristics of Berodual® Respimat® for downloading.
For further information, do not hesitate to visit www.berodual.com.